Get started
Author

Özcan Met

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
2022 · Maartje W. Rohaan, Troels H. Borch, et al. · New England Journal of Medicine · 569
PDF
Clinical advances and ongoing trials of mRNA vaccines for cancer treatment
2022 · Cathrine Lund Lorentzen, John B Haanen, et al. · The Lancet Oncology · 522
PDF
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
2016 · Rikke Andersen, Marco Donia, et al. · Clinical Cancer Research · 317
Principles of adoptive T cell therapy in cancer
2018 · Özcan Met, Kasper Mølgaard Jensen, et al. · Seminars in Immunopathology · 213
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
2012 · Eva Ellebaek, Trine Zeeberg Iversen, et al. · Journal of Translational Medicine · 172
PDF
In vivo dendritic cell reprogramming for cancer immunotherapy
2024 · Ervin Ascic, Fritiof Åkerström, et al. · Science · 147
PDF
Adoptive cell therapy with tumor-infiltrating lymphocytes in patients with metastatic ovarian cancer: a pilot study
2018 · Magnus Pedersen, Marie Christine Wulff Westergaard, et al. · OncoImmunology · 124
PDF
T-cell Responses to Oncogenic Merkel Cell Polyomavirus Proteins Distinguish Patients with Merkel Cell Carcinoma from Healthy Donors
2014 · Rikke Lyngaa, Natasja Wulff Pedersen, et al. · Clinical Cancer Research · 100
INDEL detection, the ‘Achilles heel’ of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels
2020 · Eric Paul Bennett, Bent Larsen Petersen, et al. · Nucleic Acids Research · 99
Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer
2020 · Anders Handrup Kverneland, Magnus Pedersen, et al. · Oncotarget · 99
PDF
The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy
2017 · M O Holmström, E Martinenaite, et al. · Leukemia · 93
Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study
2017 · Per Kongsted, Troels Holz Borch, et al. · Cytotherapy · 89
Restoring tumor immunogenicity with dendritic cell reprogramming
2023 · Olga Zimmermannova, Alexandra G. Ferreira, et al. · Science Immunology · 85
PDF
HLA-Restricted CTL That Are Specific for the Immune Checkpoint Ligand PD-L1 Occur with High Frequency in Cancer Patients
2013 · Shamaila Munir, Gitte Holmen Andersen, et al. · Cancer Research · 84
CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironment
2016 · Evelina Martinenaite, Shamaila Munir Ahmad, et al. · OncoImmunology · 80
PDF
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy
2022 · Christopher Aled Chamberlain, Eric Paul Bennett, et al. · Molecular Therapy — Oncolytics · 77
PDF
Chemokine receptor engineering of T cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model
2018 · Manja Idorn, Signe Koggersbøl Skadborg, et al. · OncoImmunology · 76
PDF
T-cell Responses in the Microenvironment of Primary Renal Cell Carcinoma—Implications for Adoptive Cell Therapy
2018 · Rikke Andersen, Marie Christine Wulff Westergaard, et al. · Cancer Immunology Research · 75
PDF
Tumor-infiltrating lymphocytes for adoptive cell therapy: recent advances, challenges, and future directions
2022 · Joachim Stoltenborg Granhøj, Agnete Witness Præst Jensen, et al. · Expert Opinion on Biological Therapy · 74
Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types
2021 · Anders Handrup Kverneland, Christopher Aled Chamberlain, et al. · Journal for ImmunoTherapy of Cancer · 74
PDF
T cells isolated from patients with checkpoint inhibitor-resistant melanoma are functional and can mediate tumor regression
2018 · R. Andersen, T.H. Borch, et al. · Annals of Oncology · 74
CTLA-4 blockade boosts the expansion of tumor-reactive CD8+ tumor-infiltrating lymphocytes in ovarian cancer
2020 · Christina Friese, Katja Harbst, et al. · Scientific Reports · 70
PDF
In-chip fabrication of free-form 3D constructs for directed cell migration analysis
2013 · Mark Holm Olsen, Gertrud Malene Hjortø, et al. · Lab on a Chip · 64
PDF
Simplified protocol for clinical-grade tumor-infiltrating lymphocyte manufacturing with use of the Wave bioreactor
2014 · Marco Donia, Signe Møllebæk Larsen, et al. · Cytotherapy · 60
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms
2021 · Jacob Handlos Grauslund, Morten Orebo Holmström, et al. · Frontiers in Oncology · 59
PDF
Works count: 183
Citation count: 5,029
H-index: 38
I10-index: 71
Year
Topic
Type